Walk in nasal endoscopy (WINES) study: a pilot evaluation of the safety and feasibility, and cost savings of introducing a radically new approach to upper gastrointestinal (GI) endoscopy

ISRCTN ISRCTN35624133
DOI https://doi.org/10.1186/ISRCTN35624133
Secondary identifying numbers N0077132412
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
05/12/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr A Cole
Scientific

Southern Derbyshire Acute Hospitals NHS Trust
Derby City General Hospital
Uttoxeter Road
Derby
DE22 3NE
United Kingdom

Phone +44 (0)1332 340131 ext 5046
Email abc@email.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Scientific titleWalk in nasal endoscopy (WINES) study: a pilot evaluation of the safety and feasibility, and cost savings of introducing a radically new approach to upper gastrointestinal (GI) endoscopy
Study objectivesEvaluation of safety and feasibility of a walk in two week cancer waiting list upper GI endoscopy using nasal endoscope and only one assistant. A single consultant ATC doing the procedures.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCancer: Gastrointestinal
InterventionNasal endoscopy is currently performed in the endoscopy unit at Derby City General Hospital but in a procedure analogous to conventional endoscopy using two nurse assistants. The study will be a pilot randomised controlled study comparing conventional with nasal (ultraslim endoscopy) to assess primarily the safety and feasibility of performing nasal endoscopy with just one assistant and the patient in a seated position.
Intervention typeOther
Primary outcome measurePrimary endpoints will be the proportion of cases in which this procedure could be performed and the number of early to late (within 1 week) complications. Assessment of safety will be by pro forma records of complications during endoscopy and prior to discharge and by using a patient questionnaire administered 1 week later.
The endoscopist will assess the feasibility of the nasal procedure. Completeness of endoscopy and visualisation of the duodenum, antrum, body and fundus of the stomach and oesophagus will be recorded.
Secondary outcome measuresSecondary endpoints will be a questionnaire of the patients acceptability of the procedure and a preliminary assessment of the savings in staff costs of this procedure.
Overall study start date21/10/2003
Completion date01/12/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaPatients attending for endoscopy through two-week cancer waiting list.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment21/10/2003
Date of final enrolment01/12/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Southern Derbyshire Acute Hospitals NHS Trust
Derby
DE22 3NE
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Southern Derbyshire Acute Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan